ADVFN - ニュース

S&P 500

5,648.50

0.31%

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/07/16	21 : 02	Cointelegraph	Mt. Gox repayments will only cause Bitcoin sell pressure among ‘paper hands’ — Analyst	COIN:BTCUSD	Bitcoin
2024/07/16	21 : 02	PR Newswire (US)	Raven SR Awarded €1.4M for Flagship Project in Spain
2024/07/16	21 : 02	PR Newswire (US)	Digital Yalo Welcomes Erica McHugh as Senior Executive: A New Chapter of Growth and Innovation
2024/07/16	21 : 02	GlobeNewswire Inc.	Cimilre Wins “Breast Pump Technology Innovation of the Year” In 2024 Baby Innovation Awards
2024/07/16	21 : 02	PR Newswire (US)	Tampa General Rises to 2nd Highest-Ranked Hospital in the Sunshine State, According to U.S. News & World Report
2024/07/16	21 : 02	PR Newswire (US)	SmartRecruiters Announces SmartAnalytics Pro: Taking Data-Driven Decisions to the Next Level
2024/07/16	21 : 01	GlobeNewswire Inc.	YieldMax™ ETFs Announces Monthly Distributions on Fund of Funds and Ultra ETFs	NYSE:YMAX	YieldMax Universe Fund of Option Income ETFs
2024/07/16	21 : 01	GlobeNewswire Inc.	YieldMax™ ETFs Announces Monthly Distributions on Fund of Funds and Ultra ETFs	NYSE:ULTY	Tidal Trust II YieldMax Ultra Option Income Strategy
2024/07/16	21 : 01	GlobeNewswire Inc.	YieldMax™ ETFs Announces Monthly Distributions on Fund of Funds and Ultra ETFs	NYSE:YMAG	YieldMax Magnificent 7 Fund of Option Income ETFs
2024/07/16	21 : 01	Business Wire	Harmonic Protect launches to provide zero-touch data protection for the GenAI era
2024/07/16	21 : 01	Business Wire	Skyworks Sets Date for Third Quarter Fiscal 2024 Earnings Release and Conference Call	NASDAQ:SWKS	Skyworks Solutions Inc
2024/07/16	21 : 01	GlobeNewswire Inc.	Celldex Therapeutics Initiates Global Phase 3 Program for Barzolvolimab in Patients with Chronic Spontaneous Urticaria	NASDAQ:CLDX	Celldex Therapeutics Inc
2024/07/16	21 : 01	GlobeNewswire Inc.	Xometry to Announce Second Quarter 2024 Financial Results on August 8, 2024	NASDAQ:XMTR	Xometry Inc
2024/07/16	21 : 01	PR Newswire (Canada)	Suspension de la négociation par l'Organisme canadien de réglementation des investissements - CUB	TSXV:CUB	CubicFarm Systems Corp
2024/07/16	21 : 01	GlobeNewswire Inc.	Storkcraft Wins “Crib Accessory Product of the Year” In 2024 Baby Innovation Awards
2024/07/16	21 : 01	PR Newswire (Canada)	Canadian Investment Regulatory Organization Trading Halt - VSBY
2024/07/16	21 : 01	PR Newswire (US)	HUB INTERNATIONAL STRENGTHENS EMPLOYEE BENEFITS AND ANNUITY SERVICES WITH ACQUISITION OF TAS INSURANCE SERVICES, INC. IN CALIFORNIA
2024/07/16	21 : 00	NEWSBTC	Why Is The Ethereum Price Up Today?	COIN:FLOWUSD	Flow
2024/07/16	21 : 00	NEWSBTC	Why Is The Ethereum Price Up Today?	COIN:SOLUSD	Solana
2024/07/16	21 : 00	NEWSBTC	Why Is The Ethereum Price Up Today?	COIN:ETHUSD	Ethereum
2024/07/16	21 : 00	NEWSBTC	Why Is The Ethereum Price Up Today?	COIN:MINAUSD	Mina
2024/07/16	21 : 00	NEWSBTC	Why Is The Ethereum Price Up Today?	COIN:BTCUSD	Bitcoin
2024/07/16	21 : 00	GlobeNewswire Inc.	Qorvo® to Webcast Quarterly Earnings Conference Call on July 30, 2024	NASDAQ:QRVO	Qorvo Inc
2024/07/16	21 : 00	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:GRAY	Graybug Vision Inc
2024/07/16	21 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVAX	Evaxion Biotech AS
2024/07/16	21 : 00	GlobeNewswire Inc.	PayTomorrow Integrates Katapult into Its Waterfall Application Process	NASDAQ:KPLTW	Katapult Holdings Inc
2024/07/16	21 : 00	Business Wire	Bojangles Brings Back BBQ Pulled Pork Sandwich with Exclusive WWE Collectible Cups
2024/07/16	21 : 00	GlobeNewswire Inc.	Independent Living Systems (ILS) Works with State, County and Local Leaders to Help Displaced Residents
2024/07/16	21 : 00	Business Wire	Ventus Therapeutics Significantly Expands its Presence in Montreal, Canada with Opening of a New Laboratory and Office Facility
2024/07/16	21 : 00	GlobeNewswire Inc.	Lisata Therapeutics Announces Completion of Enrollment in its Phase 2a BOLSTER Trial of Certepetide in First-Line Cholangiocarcinoma	NASDAQ:LSTA	Lisata Therapeutics Inc